Circulation Journal Vol.72, December 2008 months); and (4) successful PCI (residual narrowing <20%) of the culprit lesion (de novo lesion) during the initial hospitalization. We did not include patients with a previous history of bypass surgery, a left ventricular ejection fraction <30%, or ST-segment elevation ACS. We also excluded patients who underwent PCI for nonculprit lesions or had any complication after PCI. All patients gave informed consent. The protocol for the study was approved by the International Review Boards.
Analysis of Biochemical Markers
Blood samples for the measurement of plasma levels of high-sensitivity (hs) CRP were serially taken during the initial hospitalization and at the time of follow-up CAG. The hs-CRP levels were measured by Nanopia CRP (Daiichi Pure Chemicals, Tokyo, Japan). Lipid profiles were also measured on initial admission and at follow-up CAG. The low-density lipoprotein-cholesterol (LDL-C) levels were measured by Cholestest LDL (Daiichi Pure Chemicals, Tokyo, Japan). In addition, a quantitative assay for cardiacspecific troponin T (Roche Diagnostic, Tokyo, Japan; detection limit, 0.1 ng/ml of cardiac-specific troponin T) was performed on admission. A troponin T level ≥0.1 ng/ml was defined as positive. In patients who were negative for troponin T within 6 h after the onset of symptoms, the test was repeated at 6-8 h.
Angiographic Analysis
The patients' clinical management and the decision to proceed to cardiac catheterization and PCI were left to the discretion of the attending cardiologist. All patients underwent diagnostic CAG at a mean of 3 days after admission, PCI a mean of 6 days after admission, and follow-up diagnostic CAG a mean of 7 months after admission. Images of the coronary tree were obtained in routine standardized projections with a Bicor-Plus system (SIEMENS). The images were recorded as appropriate and reproduced at the time of follow-up angiography. After direct intracoronary injection of 2.5 mg isosorbide dinitrate into the left and right coronary arteries to exclude the effects of coronary spasm, diagnostic and follow-up CAG images were obtained. Quantitative coronary angiography (QCA-CMS, version 4.0; MEDIS Imaging Systems, Leiden, the Netherlands) was used to analyze the images of the coronary tree. Pairs of first and follow-up coronary angiograms obtained in the same projection were quantitatively assessed by a single cardiologist who was unaware of all other clinical data. The stem of a Judkins coronary catheter was used for calibration to determine absolute measurements in millimeters. For each segment, measurements were carried out on end-diastolic frames in which the severity of stenosis appeared maximal. A stenosis >50% was considered clinically significant.
The culprit lesion was considered to be the lesion with the most severe narrowing or the lesion with complex morphology, intracoronary thrombus, or both. Stenosis morphol- ogy was assessed in coronary lesions with ≥30% reduction in diameter. We excluded lesions within 20 mm of the culprit lesion. Stenosis was classified as complex (eccentric, with overhanging edges, irregular borders, and/or showing ulceration or thrombus) or smooth (concentric or eccentric lesions with smooth edges, in the absence of complex features). 12, 14 Similar to a previous study, 15 rapid progression was diagnosed in the presence of any of the following: ≥10% reduction in the diameter of a preexisting ≥50% stenosis, ≥30% reduction in the diameter of a <50% stenosis, the development of a new stenosis with a ≥30% reduction in the diameter of a segment that was normal on the first angiogram, or the progression of any lesion to total occlusion on follow-up CAG. 12 
Statistical Analysis
Results for normally distributed continuous variables are expressed as means ± SD; continuous variables that were not normally distributed are presented as medians and interquartile intervals; and categorical data are expressed as percentages. Univariate analyses were conducted using the unpaired 2-tailed t-test and the Mann-Whitney U test for continuous variables, as appropriate, to assess differences between groups. Categorical variables were compared using the chi-square test (Fisher's exact test was used when applicable). P values <0.05 were considered to indicate statistical significance. A multivariate logistic regression analysis was used to identify clinical predictors of rapid progression of nonculprit lesions among the variables associated with such progression on univariate analysis (p<0.05). Odds ratios and 95% confidence intervals were calculated. Data were analyzed using SPSS (Release 10, SPSS Inc, Chicago, IL, USA).
Results
We analyzed a total of 153 culprit lesions and 307 nonculprit lesions (mean, 2.01 per patient). During follow-up, 43 of the 153 patients (28%) had rapid progression of nonculprit lesions: 22 patients had ≥10% reduction in the diameter of a preexisting ≥50% stenosis, 19 had ≥30% reduction in the diameter of a preexisting <50% stenosis, 8 had a new lesion with ≥30% stenosis in a previously normal segment, and 1 had progression of a lesion to total occlusion on follow-up angiography. Patients were classified into 2 groups according to the presence (n=43) or absence (n=110) of rapid progression of nonculprit lesions. When at least 1 lesion showed progression, we categorized the patient as a progressor.
Clinical Characteristics
The baseline and follow-up clinical characteristics of the 2 groups are summarized in Table 1 . The 2 groups were similar with respect to age, sex, coronary risk factors, the rates of positive troponin-T on admission, treatment other than statins, and lipid profiles, except for LDL-C. At follow-up, statin use was less frequent and LDL-C levels were higher in the patients with rapid progression of nonculprit lesions than in those without rapid progression.
CRP Levels
Levels of hs-CRP levels on admission, 24 h after admis- sion, 24 h after PCI, and 48 h after PCI were significantly higher in the patients with rapid progression than in those without rapid progression (Table 2) .
Angiographic Findings
Culprit-lesion morphology, multivessel disease, ischemiarelated artery, procedural variables at initial hospitalization, angiographic follow-up period, and the rate of restenosis of culprit lesions were similar in the 2 groups (Table 3) .
Stenosis Morphology
Coronary stenosis morphology was assessable on the first angiogram in 307 lesions with ≥30% reduction in lumen diameter. We identified 123 complex lesions (40%). The rate of multiple complex lesions (at least 2 complex lesions including culprit lesions) was significantly higher in the patients with rapid progression than in those without rapid progression. The rate of multiple smooth lesions (at least 2 smooth lesions) did not differ between the 2 groups (Table 3) .
Multivariate Analysis
Univariate analysis revealed that rapid progression of nonculprit lesions was associated with CRP level on admission (p<0.001), CRP level at 48 h after PCI (p=0.001), the presence of multiple complex lesions (p=0.001), statin use at follow-up (p=0.008), and LDL-C level at follow-up (p= 0.032). Multivariate logistic regression analysis showed that elevated CRP level on admission (hs-CRP ≥0.166 mg/dl, median value), post-PCI CRP elevation (hs-CRP level at 48 h after PCI ≥1.586 mg/dl, median value), and the presence of multiple complex lesions were independent predictors of the rapid progression of nonculprit lesions (Table 4) . Fig 1 shows the proportion of patients with rapid progression of nonculprit lesions, classified according to the levels of CRP on admission and at 48 h after PCI. Elevation of the admission CRP and post-PCI CRP levels was marginally associated with the frequency of progression of nonculprit complex lesions, but not with the progression of nonculprit smooth lesions.
Clinical Outcomes
None of the subjects died or underwent bypass surgery. Before follow-up CAG, 3 patients were admitted because of recurrent ACS requiring PCI. Recurrence of ACS was attributed to the progression of nonculprit lesions. All 3 patients had admission CRP elevation as well as post-PCI CRP elevation, and 2 of these patients had multiple complex lesions at the time of initial CAG.
Discussion
This study showed that elevated levels of CRP both on admission and at 48 h after PCI were independently associated with the rapid angiographic progression of nonculprit lesions, especially complex lesions, in patients with NSTE-ACS who underwent PCI for culprit lesions.
Recent clinical and histopathological data suggest that inflammation plays an important role in plaque instability and the progression of coronary atherosclerosis. 16 Kaski et al have shown that angiographic complex stenoses are more likely to progress rapidly as compared with smooth lesions in patients with stable angina. 17 Zouridakis et al reported that elevated CRP levels are independently related to the rapid progression of coronary artery disease after adjustment for the presence of angiographically complex lesions in patients with stable angina. 12 Our data confirm and extend these previous findings in patients with NSTE-ACS. Several studies have found that elevated CRP levels at admission and multiple angiographic complex lesions [18] [19] [20] are associated with poor outcomes in patients with ACS. 8, 9 Goldstein et al demonstrated that the highest incidence of cardiac events was related to multiple complex plaques and elevated CRP levels. 21 Our study in patients with NSTE-ACS showed that an elevated CRP level at admission and the presence of multiple complex lesions was associated with the rapid progression of nonculprit lesions, especially complex lesions. In patients with NSTE-ACS, ruptured plaque in culprit lesions is usually treated by PCI, after which the CRP level increases in a time-dependent manner, with the maximum response at 48 h. 22, 23 Some studies, but not all, have shown that increased levels of CRP after PCI predict the occurrence of restenosis. 24, 25 In our study, elevated CRP levels were not related to restenosis (data not shown). The recent clinical introduction of drug-eluting stents has reduced restenosis rates, so the angiographic course of nonculprit lesions, rather than culprit lesions, has become a major clinical issue with important therapeutic implications. However, the relation between increased CRP levels after PCI and the angiographic progression of nonculprit lesions remains unclear. To our knowledge, this is the first study to show that an elevated CRP level after PCI was associated with the rapid progression of nonculprit lesion in patients with NSTE-ACS who underwent PCI for culprit lesions. Several mechanisms can trigger an inflammatory response after PCI. First, the trauma associated with the diagnostic part of the procedure may trigger an inflammatory response. Goldberg et al reported that uncomplicated diagnostic CAG increases the CRP level in patients with stable angina. 26 Liuzzo et al showed that diagnostic CAG increases the CRP and interleukin-6 levels in patients with unstable angina who had elevated levels of CRP, indicating inflammatory hyperresponsiveness to even mild stimuli. 27 Second, the rise in the CRP level after PCI has been generally attributed to inflammatory stimuli associated with plaque disruption and coronary artery injury during balloon inflation and stent implantation. Disruption of vulnerable plaque probably not only gives rise to additional inflammatory stimuli, but also causes microembolization, 28 resulting in low-grade myocardial necrosis, which has been suggested to be the main source of inflammatory stimuli in patients with unstable angina, especially those with increased levels of CRP. 29 Furthermore, Inoue et al suggested that CRP is endogenously produced in the vessel wall or in coronary atherosclerotic plaques injured by PCI, especially when such plaques are vulnerable. 25 Delineation of the precise mechanism underlying the rapid progression of nonculprit lesions was unfortunately beyond the scope of this angiographic study. However, histological studies have shown that rapid progression of nonculprit lesions can result from negative remodeling and organization of plaque hemorrhages or from repeated subclinical cycles of rupture, hemorrhage, and organization. 6, [30] [31] [32] Rapid progression of stenosis, regardless of whether such stenosis is clinically silent or associated with acute coronary events, has been shown to be a powerful predictor of cardiovascular risk. 13, 14 Recent studies have suggested that CRP is not merely a marker of inflammation, but has complex modulatory effects that participate in inflammatory processes associated with atherogenesis. Our findings suggest a link among inflammatory activity, as reflected by elevated CRP levels, the angiographic extent of coronary plaque instability, and the progression of coronary artery disease in the setting of NSTE-ACS. For patients with elevated CRP levels in the acute phase, more aggressive treatment to prevent the progression of atherosclerosis might be necessary. Studies of patients with coronary artery disease have shown that statin therapy reduces CRP levels and that lower CRP levels are associated with slower progression of atherosclerosis and lower event rates. 33, 34 In the present study, statin use at follow-up did not differ significantly between nonprogressors and progressors in our multivariate analysis. Because our study population was small, further studies in larger numbers of patients are required.
Study Limitations
First, this was a small retrospective study that included only patients with NSTE-ACS who underwent PCI for culprit lesions during the initial hospitalization. Patients who required PCI for >1 lesion were excluded; however, such patients are probably at higher risk for rapid progression and coronary events. These exclusion criteria may have introduced a bias. The number of men in our study seems to be relatively higher than in previous studies. 19, 20 However, we believe that the strict eligibility criteria enabled us to demonstrate differences in the clinical features of patients with and those without rapid progression of nonculprit lesions. Second, in patients with nonculprit lesions in the same coronary artery as the culprit lesion, PCI with a guide wire for the culprit lesion during the initial hospitalization may injure the plaques and the vessel wall, potentially triggering the rapid progression of nonculprit lesions. In our study, however, there was no significant difference between the culprit coronary artery and the nonculprit artery in the rate of rapid progression of nonculprit lesions (data not shown). Third, CAG is a "lumenogram" and therefore provides no information regarding phenomena occurring within the vessel wall. Intravascular ultrasonography or angioscopy is likely to provide more accurate information regarding atherosclerotic burden. However, in this type of study, it is important to evaluate the entire coronary artery tree. It is not acceptable to use intravascular ultrasonography or angioscopy to assess all branches that are visible angiographically. Angiography is the only diagnostic tool widely used in clinical practice.
Conclusions
Multiple complex lesions, elevated baseline inflammatory activity, and an augmented inflammatory response to interventions, as reflected by increased CRP levels, are predictive factors for the rapid progression of nonculprit lesions in patients with NSTE-ACS who undergo PCI for culprit lesions.
